Literature DB >> 25721052

Potential anti-obesogenic properties of non-digestible carbohydrates: specific focus on resistant dextrin.

Mark R Hobden1, Laetitia Guérin-Deremaux2, Ian Rowland1, Glenn R Gibson1, Orla B Kennedy1.   

Abstract

Alterations in the composition and metabolic activity of the gut microbiota appear to contribute to the development of obesity and associated metabolic diseases. However, the extent of this relationship remains unknown. Modulating the gut microbiota with non-digestible carbohydrates (NDC) may exert anti-obesogenic effects through various metabolic pathways including changes to appetite regulation, glucose and lipid metabolism and inflammation. The NDC vary in physicochemical structure and this may govern their physical properties and fermentation by specific gut bacterial populations. Much research in this area has focused on established prebiotics, especially fructans (i.e. inulin and fructo-oligosaccharides); however, there is increasing interest in the metabolic effects of other NDC, such as resistant dextrin. Data presented in this review provide evidence from mechanistic and intervention studies that certain fermentable NDC, including resistant dextrin, are able to modulate the gut microbiota and may alter metabolic process associated with obesity, including appetite regulation, energy and lipid metabolism and inflammation. To confirm these effects and elucidate the responsible mechanisms, further well-controlled human intervention studies are required to investigate the impact of NDC on the composition and function of the gut microbiota and at the same time determine concomitant effects on host metabolism and physiology.

Entities:  

Keywords:  AXOS arabinoxylan-oligosaccharides; FFAR free-fatty acid receptor; FOS fructo-oligosaccharides; GLP-1 glucagon-like peptide-1; Metabolism; NDC non-digestible carbohydrate; Non-digestible carbohydrates; Obesity; PYY peptide YY; Prebiotics; Resistant dextrin

Mesh:

Substances:

Year:  2015        PMID: 25721052     DOI: 10.1017/S0029665115000087

Source DB:  PubMed          Journal:  Proc Nutr Soc        ISSN: 0029-6651            Impact factor:   6.297


  5 in total

1.  Intake of kale suppresses postprandial increases in plasma glucose: A randomized, double-blind, placebo-controlled, crossover study.

Authors:  Sumio Kondo; Asahi Suzuki; Mihoko Kurokawa; Keiji Hasumi
Journal:  Biomed Rep       Date:  2016-09-29

2.  Starch-enriched diet modulates the glucidic profile in the rat colonic mucosa.

Authors:  Maria Gabriella Gabrielli; Daniele Tomassoni
Journal:  Eur J Nutr       Date:  2017-04-09       Impact factor: 5.614

3.  The Promising Role of Microbiome Therapy on Biomarkers of Inflammation and Oxidative Stress in Type 2 Diabetes: A Systematic and Narrative Review.

Authors:  Pradipta Paul; Ridhima Kaul; Basma Abdellatif; Maryam Arabi; Rohit Upadhyay; Reya Saliba; Majda Sebah; Ali Chaari
Journal:  Front Nutr       Date:  2022-05-25

4.  Diet Supplementation with NUTRIOSE, a Resistant Dextrin, Increases the Abundance of Parabacteroides distasonis in the Human Gut.

Authors:  Florence Thirion; Kévin Da Silva; Florian Plaza Oñate; Anne-Sophie Alvarez; Clémentine Thabuis; Nicolas Pons; Magali Berland; Emmanuelle Le Chatelier; Nathalie Galleron; Florence Levenez; Coralie Vergara; Hélène Chevallier; Laetitia Guérin-Deremaux; Joël Doré; Stanislav D Ehrlich
Journal:  Mol Nutr Food Res       Date:  2022-04-04       Impact factor: 6.575

Review 5.  Selective Manipulation of the Gut Microbiota Improves Immune Status in Vertebrates.

Authors:  Ana Montalban-Arques; Peter De Schryver; Peter Bossier; Gregor Gorkiewicz; Victoriano Mulero; Delbert Monroe Gatlin; Jorge Galindo-Villegas
Journal:  Front Immunol       Date:  2015-10-09       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.